Analysts expect Adaptive Biotechnologies Corp to report revenue of 76.35 M for Q4 26, against a range of 74.05 M to 78.64 M. The most recent reported quarter, Q3 26, came in at 83.90 M, a 21.1% beat against the 69.28 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 46.44 M | 47.46 M | 52.44 M | 58.88 M | 93.97 M | 71.68 M | 70.90 M | 71.55 M | 83.90 M | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | 39.29 M | 50.59 M | 43.07 M | 49.85 M | 66.22 M | 62.57 M | 67.02 M | 68.01 M | 74.44 M | 78.64 M | 86.35 M | 101.64 M | 101.85 M | 101.52 M | 102.44 M | 117.50 M | 132.36 M | |||||||||
| Low Estimate | 36.24 M | 45.68 M | 36.49 M | 45.83 M | 59.92 M | 54.79 M | 61.37 M | 59.50 M | 64.12 M | 74.05 M | 78.70 M | 83.77 M | 91.76 M | 85.64 M | 90.62 M | 101.11 M | 113.73 M | |||||||||
| Consensus Estimate | 37.76 M | 48.13 M | 39.78 M | 47.84 M | 63.07 M | 58.68 M | 64.20 M | 63.76 M | 69.28 M | 76.35 M | 82.52 M | 92.71 M | 96.80 M | 93.58 M | 96.53 M | 109.30 M | 123.05 M |
Analysts expect Adaptive Biotechnologies Corp to report earnings per share of -0.07 for Q4 26, against a range of -0.07 to -0.07. The most recent reported quarter, Q3 26, came in at 0.02, a 119.9% beat against the -0.09 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.22 | -0.23 | -0.20 | -0.17 | 0.06 | -0.09 | -0.13 | -0.25 | 0.02 | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | -0.25 | -0.24 | -0.25 | -0.22 | -0.15 | -0.18 | -0.14 | -0.12 | -0.09 | -0.07 | -0.10 | -0.04 | 0.07 | 0.02 | -0.06 | -0.05 | 0.11 | |||||||||
| Low Estimate | -0.29 | -0.26 | -0.29 | -0.26 | -0.17 | -0.22 | -0.16 | -0.14 | -0.09 | -0.07 | -0.12 | -0.04 | 0.05 | 0.02 | -0.08 | -0.05 | 0.11 | |||||||||
| Consensus Estimate | -0.27 | -0.25 | -0.27 | -0.24 | -0.16 | -0.20 | -0.15 | -0.13 | -0.09 | -0.07 | -0.11 | -0.04 | 0.06 | 0.02 | -0.07 | -0.05 | 0.11 |
Pull Wall Street consensus for Adaptive Biotechnologies Corp (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=ADPT&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "ADPT", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=ADPT&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();